Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 25, 1996 - Issue 5-6
7
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Nasal-Associated Lymphoid Tissue is an Inductive Site for Rat Tear IgA Antibody Responses

, , , , &
Pages 387-396 | Published online: 07 Jul 2009
 

Abstract

The role of nasal-associated lymphoid tissue (NALT) as a mucosal inductive site for tear IgA antibody responses was investigated in the rat model. Fluorescent microspheres were shown to access and be taken up by NALT after intranasal or ocular-topical administration, although fewer microspheres were found in the latter case. Tear IgA anti-DNP antibody responses to dinitrophenylated Streptococcus pneumoniae were 6 μg/ml at day 7, 10 μg/ml at day 10, and were still detectable on day 21 (5 μg/ml) following ocular or gastrointestinal immunization. Intranasal immunization induced tear IgA responses which were 1.7-fold higher at day 7 (10 μg/ml), peaked by day 10 (14 μg/ml) and were still 1.6-fold higher (8 μg/ml) at day 21 than responses of ocular or gastrointestinal groups. These findings suggest that intranasal immunization may be more effective than ocular or gastrointestinal administration in eliciting tear IgA antibody responses and, taken together with the microsphere data, indicate that NALT can serve as an inductive site for ocular mucosal IgA responses.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.